Fresh Tracks Therapeutics Stock Debt To Equity
| FRTXDelisted Stock | USD 0.78 0.09 10.34% |
Fresh Tracks Therapeutics fundamentals help investors to digest information that contributes to Fresh Tracks' financial success or failures. It also enables traders to predict the movement of Fresh Pink Sheet. The fundamental analysis module provides a way to measure Fresh Tracks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresh Tracks pink sheet.
Fresh |
Fresh Tracks Therapeutics Company Debt To Equity Analysis
Fresh Tracks' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Fresh Tracks Debt To Equity | 0 % |
Most of Fresh Tracks' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresh Tracks Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Fresh Tracks Therapeutics has a Debt To Equity of 0.002%. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
Fresh Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresh Tracks' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresh Tracks could also be used in its relative valuation, which is a method of valuing Fresh Tracks by comparing valuation metrics of similar companies.Fresh Tracks is currently under evaluation in debt to equity category among its peers.
Fresh Fundamentals
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.42 | ||||
| Profit Margin | (0.89) % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | (4.04 M) | ||||
| Shares Outstanding | 5.97 M | ||||
| Shares Owned By Insiders | 11.62 % | ||||
| Shares Owned By Institutions | 8.96 % | ||||
| Number Of Shares Shorted | 50.18 K | ||||
| Price To Book | 0.45 X | ||||
| Price To Sales | 0.48 X | ||||
| Revenue | 6.94 M | ||||
| Gross Profit | (27.83 M) | ||||
| EBITDA | (21.09 M) | ||||
| Net Income | (21.1 M) | ||||
| Cash And Equivalents | 14.48 M | ||||
| Cash Per Share | 5.04 X | ||||
| Total Debt | 49 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 6.36 X | ||||
| Book Value Per Share | 1.85 X | ||||
| Cash Flow From Operations | (19.34 M) | ||||
| Short Ratio | 0.69 X | ||||
| Earnings Per Share | (2.32) X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 13 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 4.84 M | ||||
| Total Asset | 10.27 M | ||||
| Retained Earnings | (166.47 M) | ||||
| Working Capital | 7.01 M | ||||
| Z Score | 31.28 | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 10.27 M |
About Fresh Tracks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresh Tracks Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresh Tracks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresh Tracks Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Fresh Pink Sheet
If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |